Published in Semin Respir Crit Care Med on March 14, 2016
Simultaneous presentation of two noninflammatory lung diseases in an HIV-infected patient. Ann Thorac Med (2017) 0.75
Role of TIM-4 in exosome-dependent entry of HIV-1 into human immune cells. Int J Nanomedicine (2017) 0.75
Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med (2011) 38.61
Benefits and harms of CT screening for lung cancer: a systematic review. JAMA (2012) 8.71
Trends in cancer risk among people with AIDS in the United States 1980-2002. AIDS (2006) 7.08
Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy. Lancet (1984) 5.74
Cancer burden in the HIV-infected population in the United States. J Natl Cancer Inst (2011) 4.69
The American Association for Thoracic Surgery guidelines for lung cancer screening using low-dose computed tomography scans for lung cancer survivors and other high-risk groups. J Thorac Cardiovasc Surg (2012) 4.68
Effect of immunodeficiency, HIV viral load, and antiretroviral therapy on the risk of individual malignancies (FHDH-ANRS CO4): a prospective cohort study. Lancet Oncol (2009) 4.38
Immunologic aspects of chronic obstructive pulmonary disease. N Engl J Med (2009) 4.27
A meta-analysis of the incidence of non-AIDS cancers in HIV-infected individuals. J Acquir Immune Defic Syndr (2009) 3.76
HIV infection is associated with an increased risk for lung cancer, independent of smoking. Clin Infect Dis (2007) 3.56
Highly active antiretroviral therapy and incidence of cancer in human immunodeficiency virus-infected adults. J Natl Cancer Inst (2000) 3.47
AIDS-related cancer and severity of immunosuppression in persons with AIDS. J Natl Cancer Inst (2007) 3.28
Primary pulmonary lymphoma. Eur Respir J (2002) 3.26
HIV infection and risk for incident pulmonary diseases in the combination antiretroviral therapy era. Am J Respir Crit Care Med (2010) 3.00
Increased susceptibility to pulmonary emphysema among HIV-seropositive smokers. Ann Intern Med (2000) 2.77
Life expectancy living with HIV: recent estimates and future implications. Curr Opin Infect Dis (2013) 2.60
Persistent systemic inflammation is associated with poor clinical outcomes in COPD: a novel phenotype. PLoS One (2012) 2.52
Elevated incidence of lung cancer among HIV-infected individuals. J Clin Oncol (2006) 2.46
HIV-associated Kaposi's sarcoma with a high CD4 count and a low viral load. N Engl J Med (2007) 2.26
Smoking-related health risks among persons with HIV in the Strategies for Management of Antiretroviral Therapy clinical trial. Am J Public Health (2010) 2.21
Elevated risk of lung cancer among people with AIDS. AIDS (2007) 2.20
Lung cancer screening with low-dose computed tomography: costs, national expenditures, and cost-effectiveness. J Natl Compr Canc Netw (2012) 2.13
Previous lung disease and risk of lung cancer among lifetime nonsmoking women in the United States. Am J Epidemiol (1995) 2.02
HIV infection, immunodeficiency, viral replication, and the risk of cancer. Cancer Epidemiol Biomarkers Prev (2011) 2.02
Rituximab plus infusional cyclophosphamide, doxorubicin, and etoposide in HIV-associated non-Hodgkin lymphoma: pooled results from 3 phase 2 trials. Blood (2004) 1.91
Highly active antiretroviral therapy in AIDS-associated Kaposi's sarcoma: implications for the design of therapeutic trials in patients with advanced, symptomatic Kaposi's sarcoma. J Clin Oncol (2004) 1.91
Cancer risk among participants in the women's interagency HIV study. J Acquir Immune Defic Syndr (2004) 1.90
Recrudescent Kaposi's sarcoma after initiation of HAART: a manifestation of immune reconstitution syndrome. AIDS Patient Care STDS (2005) 1.84
Impact of cigarette smoking on mortality in HIV-positive and HIV-negative veterans. AIDS Educ Prev (2009) 1.72
Survival after cancer diagnosis in persons with AIDS. J Acquir Immune Defic Syndr (2005) 1.71
Delayed diagnosis and elevated mortality in an urban population with HIV and lung cancer: implications for patient care. J Acquir Immune Defic Syndr (2006) 1.66
Kaposi's sarcoma: a result of the interplay among inflammatory cytokines, angiogenic factors and viral agents. Cytokine Growth Factor Rev (1998) 1.65
Primary liver cancer is more aggressive in HIV-HCV coinfection than in HCV infection. A prospective study (ANRS CO13 Hepavih and CO12 Cirvir). Clin Res Hepatol Gastroenterol (2011) 1.62
Motivation and patch treatment for HIV+ smokers: a randomized controlled trial. Addiction (2009) 1.61
Permanent declines in pulmonary function following pneumonia in human immunodeficiency virus-infected persons. The Pulmonary Complications of HIV Infection Study Group. Am J Respir Crit Care Med (2000) 1.56
Chronic obstructive pulmonary disease and altered risk of lung cancer in a population-based case-control study. PLoS One (2009) 1.56
HIV as an independent risk factor for incident lung cancer. AIDS (2012) 1.54
Markers of microbial translocation and risk of AIDS-related lymphoma. AIDS (2013) 1.53
Relationship between current level of immunodeficiency and non-acquired immunodeficiency syndrome-defining malignancies. Cancer (2010) 1.53
Lung cancer incidence and survival among HIV-infected and uninfected women and men. AIDS (2015) 1.47
Previous lung disease and risk of lung cancer among men and women nonsmokers. Am J Epidemiol (1999) 1.47
Lung cancer in HIV positive patients: the GICAT experience. Eur Rev Med Pharmacol Sci (2014) 1.47
Facts and fiction of the relationship between preexisting tuberculosis and lung cancer risk: a systematic review. Int J Cancer (2009) 1.45
Lymphocytic alveolitis, bronchoalveolar lavage viral load, and outcome in human immunodeficiency virus infection. Am J Respir Crit Care Med (1999) 1.42
Lung cancer in the Swiss HIV Cohort Study: role of smoking, immunodeficiency and pulmonary infection. Br J Cancer (2012) 1.41
Predicting risk of cancer during HIV infection: the role of inflammatory and coagulation biomarkers. AIDS (2013) 1.34
Lung cancer incidence and mortality among HIV-infected and HIV-uninfected injection drug users. J Acquir Immune Defic Syndr (2010) 1.33
Prior lung disease and risk of lung cancer in a large prospective study. Cancer Causes Control (2004) 1.30
Reduced risk of AIDS lymphoma in individuals heterozygous for the CCR5-delta32 mutation. Cancer Res (1999) 1.30
Perinatal genotoxicity and carcinogenicity of anti-retroviral nucleoside analog drugs. Toxicol Appl Pharmacol (2004) 1.26
CD4:CD8 ratio as a frontier marker for clinical outcome, immune dysfunction and viral reservoir size in virologically suppressed HIV-positive patients. J Int AIDS Soc (2015) 1.26
Pulmonary infections and risk of lung cancer among persons with AIDS. J Acquir Immune Defic Syndr (2010) 1.25
The clinical effectiveness and cost-effectiveness of computed tomography screening for lung cancer: systematic reviews. Health Technol Assess (2006) 1.24
Cancer incidence in women with or at risk for HIV. Int J Cancer (2001) 1.23
Immunodeficiency as a risk factor for non-AIDS-defining malignancies in HIV-1-infected patients receiving combination antiretroviral therapy. Clin Infect Dis (2011) 1.22
Comparison of molecular changes in lung cancers in HIV-positive and HIV-indeterminate subjects. JAMA (1998) 1.22
Airway obstruction is increased in pneumocystis-colonized human immunodeficiency virus-infected outpatients. J Clin Microbiol (2009) 1.20
Pneumocystis murina infection and cigarette smoke exposure interact to cause increased organism burden, development of airspace enlargement, and pulmonary inflammation in mice. Infect Immun (2008) 1.18
Lung cancer in patients with HIV-infection. Lung Cancer (1996) 1.17
Lung cancer in HIV-infected patients in the era of highly active antiretroviral therapy. J Thorac Oncol (2007) 1.15
Treatment factors affecting outcomes in HIV-associated non-Hodgkin lymphomas: a pooled analysis of 1546 patients. Blood (2013) 1.13
Lung carcinoma in 36 patients with human immunodeficiency virus infection. The Italian Cooperative Group on AIDS and Tumors. Cancer (2000) 1.13
The role of inflammation in the pathogenesis of lung cancer. Expert Opin Ther Targets (2011) 1.12
HIV infection, aging, and immune function: implications for cancer risk and prevention. Curr Opin Oncol (2012) 1.10
Human immunodeficiency virus-associated primary lung cancer in the era of highly active antiretroviral therapy: a multi-institutional collaboration. Clin Lung Cancer (2010) 1.08
The role of Kaposi sarcoma-associated herpesvirus in the pathogenesis of Kaposi sarcoma. J Pathol (2015) 1.07
HIV-associated lung infections and complications in the era of combination antiretroviral therapy. Proc Am Thorac Soc (2011) 1.05
Effect of highly active antiretroviral therapy on survival of HIV infected patients with non-small-cell lung cancer. Lung Cancer (2009) 1.05
An IL6 promoter polymorphism is associated with a lifetime risk of development of Kaposi sarcoma in men infected with human immunodeficiency virus. Blood (2000) 1.05
Understanding the roles of cytokines and neutrophil activity and neutrophil apoptosis in the protective versus deleterious inflammatory response in pneumonia. Int J Infect Dis (2012) 1.05
Pulmonary Kaposi sarcoma in the era of highly active antiretroviral therapy. HIV Med (2006) 1.04
Risk of lung cancer following nonmalignant respiratory conditions: evidence from two case-control studies in Montreal, Canada. Lung Cancer (2006) 1.04
Treatment of severe or progressive Kaposi's sarcoma in HIV-infected adults. Cochrane Database Syst Rev (2014) 1.02
The prognosis of HIV-infected patients with diffuse large B-cell lymphoma treated with chemotherapy and highly active antiretroviral therapy is similar to that of HIV-negative patients receiving chemotherapy. Haematologica (2005) 1.02
Opposite effects of HIV-1 p17 variants on PTEN activation and cell growth in B cells. PLoS One (2011) 1.01
Altered clinical course of malignant melanoma in HIV-positive patients. Arch Dermatol (2002) 1.01
Presentation and outcomes of systemic non-Hodgkin's lymphoma: a comparison between patients with acquired immunodeficiency syndrome (AIDS) treated with highly active antiretroviral therapy and patients without AIDS. Leuk Lymphoma (2006) 1.01
Increased risk of radiographic emphysema in HIV is associated with elevated soluble CD14 and nadir CD4. Chest (2014) 1.00
Does HIV adversely influence the outcome in advanced non-small-cell lung cancer in the era of HAART? Br J Cancer (2003) 1.00
Chemokine and chemokine receptor gene variants and risk of non-Hodgkin's lymphoma in human immunodeficiency virus-1-infected individuals. Blood (1999) 1.00
Safety and efficacy of cyclophosphamide, adriamycin, vincristine, prednisone and rituximab in patients with human immunodeficiency virus-associated diffuse large B-cell lymphoma: results of a phase II trial. Br J Haematol (2007) 1.00
Non-AIDS defining cancers in the D:A:D Study--time trends and predictors of survival: a cohort study. BMC Infect Dis (2013) 0.98
Human papilloma virus in non-small cell lung cancer in never smokers: a systematic review of the literature. Lung Cancer (2013) 0.97
Human immunodeficiency virus infection and non-small cell lung cancer: survival and toxicity of antineoplastic chemotherapy in a cohort study. J Thorac Oncol (2011) 0.97
Pneumocystis infection and the pathogenesis of chronic obstructive pulmonary disease. Immunol Res (2011) 0.93
Genotoxic signature in cord blood cells of newborns exposed in utero to a Zidovudine-based antiretroviral combination. J Infect Dis (2013) 0.93
Prognosis in HIV-infected patients with non-small cell lung cancer. Br J Cancer (2013) 0.92
Findings in asymptomatic HIV-infected patients undergoing chest computed tomography testing: implications for lung cancer screening. AIDS (2014) 0.92
Outcome in patients with non-hodgkin lymphoma and with or without human immunodeficiency virus infection. Clin Infect Dis (2003) 0.91
Feasibility and preliminary efficacy of a web-based smoking cessation intervention for HIV-infected smokers: a randomized controlled trial. J Acquir Immune Defic Syndr (2014) 0.90
Human immunodeficiency virus infection as a prognostic factor in surgical patients with non-small cell lung cancer. Ann Thorac Surg (2012) 0.90
Enhancement of chemical hepatocarcinogenesis by the HIV-1 tat gene. Am J Pathol (2000) 0.89
Changes in the influence of lymphoma- and HIV-specific factors on outcomes in AIDS-related non-Hodgkin lymphoma. Ann Oncol (2015) 0.88
AIDS-related primary pulmonary lymphoma. Am J Respir Crit Care Med (1998) 0.88
Primary pulmonary Hodgkin's lymphoma and a review of the literature since 2006. BMJ Case Rep (2014) 0.87
Safety of varenicline among smokers enrolled in the lung HIV study. Nicotine Tob Res (2012) 0.87
Risk of non-AIDS-defining cancers among HIV-1-infected individuals in France between 1997 and 2009: results from a French cohort. AIDS (2014) 0.87
Pulmonary malignancies in the immunocompromised patient. Respiration (1999) 0.86
Pulmonary Kaposi sarcoma in AIDS. Mayo Clin Proc (2012) 0.86